Plain-English translation of NCT04748601 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether —a medication taken by mouth—can help prevent migraines in children between 6 and 11 years old. Researchers want to see if this treatment can reduce how often these children get migraines and how much the headaches interfere with their daily activities. Some children will receive the medication while others receive a placebo (a pill with no active medicine) to see which works better.
Many children suffer from frequent migraines that disrupt school, play, and family life, but there aren't many proven prevention options available for this age group. This study aims to determine whether this medication could be a safe and effective way to help these children have fewer migraines.
You likely qualify if…
You likely don't qualify if…
If you join this study, your child will visit the clinic for screening to confirm they qualify, then be randomly assigned to take either the medication or a placebo pill daily for a set period. Throughout the study, you and your child will attend follow-up visits where the research team will ask about migraine frequency, severity, and how much the headaches are affecting school and activities. The team will also monitor for any side effects to make sure the treatment is safe.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States